Solid Organ Transplant Recipients with Pretransplant Cancer Have an Elevated Risk of Posttransplant Cancer of the Same Cancer Type By Ogkologos - March 30, 2026 126 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the Transplant Cancer Match Study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Joins WHO Global Clinical Trials Forum to Strengthen Global Oncology Research Ecosystems EMA Recommends Extension of Therapeutic Indications for Enfortumab Vedotin Selinexor plus Ruxolitinib Reduces Spleen Volume, but Does Not Improve Symptom Responses Over Ruxolitinib in Patients with JAK Inhibitor-Naïve Myelofibrosis MOST POPULAR ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ March 8, 2019 Study Finds Possible New Treatment for Metastatic Breast Cancer That Has... January 29, 2022 Steps towards a smokefree society August 31, 2022 “Giving something back”: our supporters are the beating heart of what... August 17, 2022 Load more HOT NEWS Starving cancer into submission Mom Gives Birth and Receives a Breast Cancer Diagnosis on the... Efficacy of Sunitinib in Patients with Metastatic Phaeochromocytomas and Paragangliomas Cancer in My Community: Striving to Lead People to Cancer Care...
